Perspective Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 76K | 43K | 209K | 290K | 342K | 234K | 369K | 526K |
| Cost of Goods Sold | 1.1M | 0 | 775K | 733K | 0 | 0 | 0 | 0 |
| Gross Profit | -1.1M | -968K | -566K | -443K | -390K | -475K | -300K | -46K |
| R&D Expenses | 20.2M | 32.9M | 20.3M | 12.2M | 14.3M | 12.9M | 12.0M | 9.3M |
| Operating Expenses | 27.2M | 39.8M | 27.3M | 23.6M | 21.8M | 46.4M | 18.6M | 14.3M |
| Operating Income | -28.3M | -39.8M | -27.9M | -24.0M | -21.8M | -45.0M | -18.6M | -14.3M |
| Other Income / Gains | 2.1M | 1.5M | 1.9M | 2.0M | 3.7M | 2.7M | 3.5M | 3.0M |
| Net Income | -26.2M | -37.5M | -26.0M | -21.5M | -18.2M | -40.2M | -15.1M | -11.7M |
| EPS (Diluted) | -25.28 | -0.51 | -0.35 | -0.30 | -0.25 | -0.57 | -0.21 | -0.18 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | -13.816 | -22.512 | -2.708 | -1.528 | -1.14 | -2.03 | -0.813 | -0.087 |
| General And Administrative Expenses | 7.0M | 7.0M | 7.7M | 7.7M | 7.8M | 8.2M | 7.0M | 5.5M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 7.0M | 7.0M | 7.7M | 7.7M | 7.8M | 8.2M | 7.0M | 5.5M |
| Other Expenses | 0 | -43K | -775K | 3.7M | -342K | 23.9M | 0 | 0 |
| Cost And Expenses | 28.4M | 39.8M | 28.1M | 24.3M | 21.8M | 45.2M | 18.6M | 14.3M |
| Interest Income | 2.2M | 1.6M | 2.0M | 2.2M | 2.4M | 2.6M | 3.6M | 3.1M |
| Interest Expense | 105K | 64K | 65K | 119K | 128K | -73K | 69K | 23K |
| Depreciation And Amortization | 1.1M | 1.0M | 775K | 733K | 732K | 721K | 669K | 570K |
| Ebitda | -27.2M | -37.2M | -25.1M | -21.1M | -17.3M | -41.6M | -14.4M | -10.7M |
| Ebitdaratio | -357.303 | -865.302 | -120.234 | -72.921 | -50.635 | -177.855 | -38.981 | -20.304 |
| Operating Income Ratio | -372.118 | -926.326 | -133.306 | -82.893 | -63.836 | -192.239 | -50.499 | -27.116 |
| Income Before Tax | -26.2M | -38.3M | -26.0M | -22.0M | -18.2M | -42.3M | -15.1M | -11.3M |
| Income Before Tax Ratio | -344.592 | -890.302 | -124.254 | -75.859 | -53.149 | -180.624 | -40.981 | -21.435 |
| Income Tax Expense | 0 | -793K | 0 | 0 | 0 | -2.1M | 0 | -61K |
| Net Income Ratio | -344.592 | -871.86 | -124.254 | -74.086 | -53.149 | -171.662 | -40.981 | -22.251 |
| Epsdiluted | -25.28 | -0.51 | -0.35 | -0.30 | -0.25 | -0.57 | -0.21 | -0.18 |
| Weighted Average Shs Out | 1.0M | 73.8M | 74.3M | 70.7M | 72.4M | 70.6M | 70.6M | 66.6M |
| Weighted Average Shs Out Dil | 1.0M | 73.8M | 74.3M | 70.7M | 72.4M | 70.6M | 70.6M | 66.6M |